GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Alfresa Holdings Corp (TSE:2784) » Definitions » 3-Year EPS without NRI Growth Rate

Alfresa Holdings (TSE:2784) 3-Year EPS without NRI Growth Rate : -16.10% (As of Dec. 2023)


View and export this data going back to 2003. Start your Free Trial

What is Alfresa Holdings 3-Year EPS without NRI Growth Rate?

Alfresa Holdings's EPS without NRI for the three months ended in Dec. 2023 was 円49.00.

During the past 12 months, Alfresa Holdings's average EPS without NRI Growth Rate was 38.50% per year. During the past 3 years, the average EPS without NRI Growth Rate was -16.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was -11.50% per year. During the past 10 years, the average EPS without NRI Growth Rate was 0.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Alfresa Holdings was 38.30% per year. The lowest was -23.30% per year. And the median was 2.60% per year.


Competitive Comparison of Alfresa Holdings's 3-Year EPS without NRI Growth Rate

For the Medical Distribution subindustry, Alfresa Holdings's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alfresa Holdings's 3-Year EPS without NRI Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Alfresa Holdings's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Alfresa Holdings's 3-Year EPS without NRI Growth Rate falls into.



Alfresa Holdings 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Alfresa Holdings  (TSE:2784) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Alfresa Holdings 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Alfresa Holdings's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Alfresa Holdings (TSE:2784) Business Description

Traded in Other Exchanges
N/A
Address
1-1-3 Otemachi, Chiyoda-ku, Tokyo, JPN, 100-0004
Alfresa Holdings Corp is a holding company engaged in the distribution of drugs. The company is in the Ethical Pharmaceuticals Wholesaling Business, the Self-Medication Products Wholesaling Business, the Manufacturing Business, and the Medical-Related Business. It mainly provides distributes diagnostic reagents and medical devices/equipment, health foods, supplements and other products to drug stores and pharmacies. The firm manufactures and markets high-quality active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices.

Alfresa Holdings (TSE:2784) Headlines

No Headlines